🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Although I am very pro-automation, I often roll my eyes when I see people talk about “automating science” in biotech Any serious conversation here needs to consider the way new methods are invented and scaled

People who are passionate about automating science should consider challenging themselves to move earlier in the innovation cycle Who will be the first team to develop a 0-to-1 technique natively on a robot for the first time? Who will make a robot that can cook?

Elliot Hershberg Elad Gill refers to this all the time - 1 big mega tech >> entire pharma market size. I think it has a lot to do with the structural differences. In pharma, the product comes with the expiry date (loss of patent protection) that breaks the true compounding of the asset.

Kimi K2 is **INCREDIBLE** at using tools. I built a chrome extension to chat with Google Maps, but I never posted it. All the models kept screwing up. I just replaced them with Kimi K2, and watch it easily plan an epic wine and food tour around Napa Valley for my bday!

Swap your tool calling model to Kimi K2 on Groq for better results, instantly.

I try not to get caught up in all the LLM hype... but is Kimi actually, genuinely a very good writer? Do we really have a contender to Sonnet and Opus' writing prowess, and it's open source, no less?

Awesome new offering from Ginkgo Datapoints -- we will price match any ADME service quote you get (including from Chinese or other international vendors). We plan to have the best per-compound pricing out of the gate anyway --our automation at Ginkgo allows best in class

George Church surprising (and inspiring!) takes from the Dwarkesh Patel pod - no law of physics stops gene delivery to every cell - genetic counseling is under-hyped and sees it similarly to gene editing - he believes that replacement theory of the brain is plausible - he’s

The first pivotal, FDA-enabling clinical trial of a longevity drug is now fully enrolled We will monitor these dogs for the next ~4 years, quantifying millions of data points across biological changes, quality of life, disease, + lifespan

Zymo sent me an email for an upcoming webinar they are hosting called "Advancing Long-Read 16S rRNA Metagenomics: Workflow Innovations for Robust Results". NO!!!!! 16S rRNA amplicon work is NOT metagenomics!!!!!!!!!

Many people are again interested in my work.

Is anyone routinely using plasmidsaurus for lytic, tailed, dsDNA phage sequencing? How much DNA are you sending?

I realized we hadn’t cast a wide enough net for this role originally. If you’re a student or recent grad looking to get away from the bench but want to be deeply integrated into a fast-paced research environment with a front row seat into the operations of a new type of science

This is why I stopped working on AI + spreadsheets lmao

Huh. I wonder why?

**A grand unified theory on what will happen in biotech in the next 10-20 years** the two major forces reshaping industrial biotech in the next decade are: 1. China 2. AI - and they're critically linked how? China's low R&D cost basis democratizes execution by providing

David Li Yeah, this is really well said and I agree. Western audiences have mostly scoffed at target/MOA discovery engines because there’s virtually no value capture for ideas. But like you’re saying, the medium to test these ideas definitively—chemical matter—is rapidly becoming a

After many months heads down, we at Decade are growing! We are hiring a protein biochemist to help us radically improve cancer treatment. If you like being early and making an impact, we are interested to hear from you! Details here: decade.bio/careers